Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis-Reference-Cited by-同舟云学术

Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis

Published:2007-08 Issue:2 Volume:151 Page:134-139.e1
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Konstan Michael W.,Morgan Wayne J.,Butler Steven M.,Pasta David J.,Craib Marcia L.,Silva Stefanie J.,Stokes Dennis C.,Wohl Mary Ellen B.,Wagener Jeffrey S.,Regelmann Warren E.,Johnson Charles A.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference24 articles.

1. Five- to seven-year course of pulmonary function in cystic fibrosis;Corey;Am Rev Respir Dis,1976

2. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis;Wang;N Engl J Med,1984

3. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa;Kerem;J Pediatr,1990

4. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients;Lewin;J Clin Epidemiol,1990

5. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection;Demko;J Clin Epidemiol,1995

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy;Microbiology Spectrum;2024-08-06

2. The role of environmental pollution in the development of pulmonary exacerbations in cystic fibrosis: a narrative review;Reviews on Environmental Health;2024-07-30

3. Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF;Pediatric Pulmonology;2024-07-12

4. The predictive role of lung clearance index on FEV<sub>1</sub> decline in cystic fibrosis;The Turkish Journal of Pediatrics;2024-07-11

5. Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis;Thorax;2024-06-27